Revised: 1/2026 Full Prescribing Information WARNING: RISK OF THYROID C-CELL TUMORS In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures
Semaglutide, commonly prescribed as Ozempic, primarily targets GLP-1 receptors
During her initial consultation, her weight was 109 kg, her height was 146.5 cm, and her BMI was 50.8 kg/m 2
A cut-off of 10 is usually used as a rule of thumb to distinguish between strong and weak instruments [22]
By 2024, 7% of people with obesity were prescribed these drugs, and the rate has continued to increase
What studies show: People can lose ~15% of their body weight on average with semaglutide The catch: Once the drug is stopped, weight regain is common most people regain much of their lost weight within a year